Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 22, 2021

SELL
$14.07 - $17.3 $234,814 - $288,719
-16,689 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$16.62 - $18.94 $10,221 - $11,648
615 Added 3.83%
16,689 $289,000
Q1 2021

Apr 28, 2021

SELL
$15.15 - $19.78 $1,727 - $2,254
-114 Reduced 0.7%
16,074 $277,000
Q4 2020

Jan 28, 2021

BUY
$16.86 - $19.67 $24,463 - $28,541
1,451 Added 9.85%
16,188 $298,000
Q3 2020

Oct 30, 2020

SELL
$15.4 - $20.16 $877 - $1,149
-57 Reduced 0.39%
14,737 $255,000
Q2 2020

Jul 31, 2020

SELL
$18.24 - $21.45 $2,590 - $3,045
-142 Reduced 0.95%
14,794 $269,000
Q1 2020

May 01, 2020

SELL
$16.28 - $25.63 $10,061 - $15,839
-618 Reduced 3.97%
14,936 $300,000
Q4 2019

Feb 07, 2020

SELL
$19.57 - $23.52 $292,728 - $351,812
-14,958 Reduced 49.02%
15,554 $362,000
Q3 2019

Oct 31, 2019

SELL
$19.85 - $22.76 $25,904 - $29,701
-1,305 Reduced 4.1%
30,512 $611,000
Q2 2019

Aug 02, 2019

SELL
$17.59 - $21.1 $48,020 - $57,603
-2,730 Reduced 7.9%
31,817 $0
Q1 2019

May 02, 2019

SELL
$18.01 - $20.11 $56,551 - $63,145
-3,140 Reduced 8.33%
34,547 $0
Q4 2018

Feb 06, 2019

SELL
$17.44 - $21.53 $14,422 - $17,805
-827 Reduced 2.15%
37,687 $711,000
Q3 2018

Nov 01, 2018

BUY
$19.97 - $21.96 $281,097 - $309,108
14,076 Added 57.6%
38,514 $735,000
Q2 2018

Aug 01, 2018

SELL
$20.16 - $24.68 $33,647 - $41,190
-1,669 Reduced 6.39%
24,438 $522,000
Q1 2018

May 01, 2018

BUY
$20.31 - $24.95 $26,118 - $32,085
1,286 Added 5.18%
26,107 $542,000
Q4 2017

Feb 02, 2018

BUY
$20.99 - $23.89 $98,904 - $112,569
4,712 Added 23.43%
24,821 $613,000
Q3 2017

Nov 06, 2017

BUY
$20.07 - $21.89 $403,587 - $440,186
20,109
20,109 $451,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.47B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.